Peritoneal mesothelioma is the second-most common type of mesothelioma and accounts for 10 to 20 percent of all mesothelioma cases. The cancer develops in the abdomen over a course of decades after asbestos fibers are inhaled or ingested. Modern diagnostic tests are used to detect peritoneal mesothelioma. Although the disease is usually diagnosed in the later stages of development, treatment options are available.
Some patients may be good candidates for curative treatments such as surgery, while others may elect for palliative measures alone. Overall prognosis for peritoneal mesothelioma patients is less than one year. However, life expectancy can increase with effective treatment. Working with a mesothelioma specialist helps patients receive the best possible care for their cancer, which could have a significant impact on a patient's prognosis.